monoclonal antibodies

  1. L

    NEW MIGRAINE DRUG - CGRP ANTAGONISTS - WHAT DO YOU THINK? “In 2018, the FDA approved the first calcitonin gene-related peptide (CGRP) inhibitors. These new drugs are designed to prevent episodic migraine (up to 14 headache days per month), chronic...
  2. Elie

    Rectal cancer disappears for every patient in small experimental drug study

    'Unprecedented' study appears to cure 14 patients' rectal cancer. What about other types? Promising outcome. No evidence of tumor six months later. I wonder how this fits with the bioenergetic model of health and disease.
Top Bottom